Consensus Abbott Laboratories Swiss Exchange

Equities

ABT

US0028241000

Delayed Swiss Exchange Other stock markets 11:31:05 2024-02-19 am EST			5-day change	1st Jan Change
93 ^CHF	-.--%		-.--%	-.--%

Apr. 23	Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126	MT
Apr. 22	Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating	MT

Evolution of the average Target Price on Abbott Laboratories

Price target over the last 5 years

History of analyst recommendation changes

5a113af78e12f04.rpFwSm0QIU_ZIpSbw4L-JMayOETW8umHrlJ1AKfN-vI.4rwHfjlUdhnsadzjksy1d_TEczG-x67P6R0vSOiHysWdxzYvCnITPrVh-w~b691b51fd93029f42847d3c5dbcfd716

Analyst Recommendations on Abbott Laboratories

Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126	Apr. 23	MT
Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating	Apr. 22	MT
UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept	Apr. 19	MT
RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating	Apr. 18	MT
Raymond James Adjusts Abbott Laboratories' Price Target to $124 From $127, Keeps Outperform Rating	Apr. 18	MT
Citigroup Raises Price Target on Abbott Laboratories to $128 From $126, Keeps Buy Rating	Apr. 03	MT
Barclays Raises Abbott Laboratories' Price Target to $141 From $133, Keeps Overweight Rating	Jan. 26	MT
Raymond James Adjusts Price Target on Abbott Laboratories to $127 From $124, Maintains Outperform Rating	Jan. 25	MT
Citigroup Raises Abbott Laboratories Price Target to $126 From $123, Maintains Buy Rating	Jan. 25	MT
Bernstein Raises Abbott Laboratories Price Target to $133 From $125, Maintains Outperform Rating	Jan. 25	MT
JPMorgan Raises Abbott Laboratories Price Target to $125 From $122, Maintains Overweight Rating	Jan. 25	MT
UBS Raises Abbott Laboratories Price Target to $136 From $122, Maintains Buy Rating	Jan. 22	MT
Wall St Week Ahead-Maligned US real estate sector draws buyers eyeing rate cuts	Jan. 21	RE
Wall St Week Ahead-Maligned US real estate sector draws buyers eyeing rate cuts	Jan. 19	RE
RBC Adjusts Abbott Laboratories' Price Target to $128 From $119, Keeps Outperform Rating	Jan. 11	MT
Raymond James Raises Abbott Laboratories' Price Target to $124 From $110, Maintains Outperform Rating	Jan. 03	MT
Wells Fargo Raises Price Target on Abbott Laboratories to $121 From $116, Maintains Overweight Rating	Dec. 13	MT
UBS Raises Abbott Laboratories Price Target to $122 From $118, Maintains Buy Rating	23-10-19	MT
Wells Fargo Cuts Price Target on Abbott Laboratories to $116 From $136, Maintains Overweight Rating	23-10-19	MT
Morningstar Upgrades Abbott Laboratories to Buy From Hold, $104 Price Target	23-10-19	MT
Raymond James Adjusts Abbott Laboratories Price Target to $110 From $123, Maintains Outperform Rating	23-10-19	MT
Evercore ISI Adjusts Abbott Laboratories Price Target to $106 From $110, Maintains Outperform Rating	23-10-19	MT
Morgan Stanley Adjusts Abbott Laboratories Price Target to $107 From $112, Maintains Equal Weight Rating	23-10-19	MT
Bernstein Adjusts Abbott Laboratories Price Target to $122 From $133, Maintains Outperform Rating	23-10-19	MT
Stifel Nicolaus Adjusts Abbott Laboratories Price Target to $115 From $125, Maintains Buy Rating	23-10-19	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

106.9 USD

Average target price

126.3 USD

Spread / Average Target

+18.19%

High Price Target

143 USD

Spread / Highest target

+33.78%

Low Price Target

104 USD

Spread / Lowest Target

-2.70%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Abbott Laboratories

Daiwa Securities
Barclays
UBS
RBC Capital Markets
Raymond James
Citigroup
Bernstein
JPMorgan Chase
Wells Fargo Securities
Morgan Stanley
Stifel Nicolaus
Evercore ISI
Morningstar
Wolfe Research
Mizuho Securities
BTIG
Jefferies & Co.
Goldman Sachs
BofA Securities
Atlantic Equities
SVB Leerink
Redburn
Cowen
Credit Suisse
J.P. Morgan Chase

Ratings for Abbott Laboratories

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar